Investors Watch List : Johnson & Johnson (NYSE:JNJ), VIVUS Inc. (NASDAQ:VVUS), SVB Financial Group (NASDAQ:SIVB), AT&T, Inc. (NYSE:T), Modine Manufacturing Company (NYSE:MOD)

Johnson & Johnson (NYSE:JNJ) said on Tuesday that it would pay $1.75 billion in cash for Alios BioPharma, a private biotechnology company that is working on treatments for viral diseases. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 21.20% and weekly performance is -3.03%. On last trading day company shares ended up $103.85. Johnson & Johnson (NYSE:JNJ) distance from 50-day … Continue reading Investors Watch List : Johnson & Johnson (NYSE:JNJ), VIVUS Inc. (NASDAQ:VVUS), SVB Financial Group (NASDAQ:SIVB), AT&T, Inc. (NYSE:T), Modine Manufacturing Company (NYSE:MOD)

Chris Lewis10/0310/03

News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),

Ariad Pharmaceuticals (NASDAQ:ARIA Director Sarah J. Schlesinger bought 5,200 shares of Ariad Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, September 10th. The shares were purchased at an average cost of $5.73 per share, with a total value of $29,796.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.27%. On last trading day company shares ended … Continue reading News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),

Colin Pettis09/2409/24

Active Watch List : VIVUS Inc. (NASDAQ:VVUS), Arch Coal Inc. (NYSE:ACI), FXCM Inc. (NYSE:FXCM), U.S. Global Investors (NASDAQ:GROW), Select Income REIT Common (NYSE:SIR)

VIVUS Inc. (NASDAQ:VVUS) The company on Aug. 25 announced the acquisition of a group of patents from Janssen Pharmaceuticals, Inc. covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware … Continue reading Active Watch List : VIVUS Inc. (NASDAQ:VVUS), Arch Coal Inc. (NYSE:ACI), FXCM Inc. (NYSE:FXCM), U.S. Global Investors (NASDAQ:GROW), Select Income REIT Common (NYSE:SIR)

Kristen Barton09/1609/16

Trending Stocks : VIVUS Inc. (NASDAQ:VVUS), VeriSign (NASDAQ:VRSN), Oil-Dri Corp. of America (NYSE:ODC), Orbital Sciences Corp. (NYSE:ORB), Telecom Italia S.p.A. (NYSE:TI)

VIVUS, Inc. (NASDAQ:VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the second quarter ended June 30, 2014 and provided a business update. Total net revenue was $21.9 million for the second quarter of 2014, compared to $5.5 million for the second quarter of 2013. Of the total revenue for the … Continue reading Trending Stocks : VIVUS Inc. (NASDAQ:VVUS), VeriSign (NASDAQ:VRSN), Oil-Dri Corp. of America (NYSE:ODC), Orbital Sciences Corp. (NYSE:ORB), Telecom Italia S.p.A. (NYSE:TI)

Colin Pettis08/0808/08

Hot Movers: Tesla Motors Inc (NASDAQ:TSLA), VIVUS (NASDAQ:VVUS), Teva Pharmaceutical Industries (NYSE:TEVA), Sony (NYSE:SNE), Advanced Micro Devices (NYSE:AMD)

Tesla Motors Inc (NASDAQ:TSLA) hasn’t changed the look of its Model S sedan since the sumptuous electric car first hit the market in 2012. Tesla Motors Inc (NASDAQ:TSLA) stock performance was -0.08% in last session and finished the day at $229.25. Traded volume was 5.17million shares in the last session and the average volume of the stock remained 6.63million shares. The beta of the stock remained … Continue reading Hot Movers: Tesla Motors Inc (NASDAQ:TSLA), VIVUS (NASDAQ:VVUS), Teva Pharmaceutical Industries (NYSE:TEVA), Sony (NYSE:SNE), Advanced Micro Devices (NYSE:AMD)

Colin Pettis07/0707/07

Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

Earlier this month, Vivus Inc. (NASDAQ:VVUS) said it filed a patent-infringement lawsuit against Actavis PLC ( ACT ) alleging that the drug maker’s planned generic version of weight-loss drug Qsymia infringes its patents. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 3.97% in last session and finished the day at $5.50. Traded volume was 4.47million shares in the last session and the average volume of the stock remained 3.04million … Continue reading Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

John Meady06/2306/23